Profil bibliographique

Darren Piscitelli

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées

0Citations signalées

0Affiliations récentes

Domaines associés

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesMicroscopic ColitisSpondyloarthritis Studies and TreatmentsHemophilia Treatment and Research

Publications récentes

2026 articleOpenAlex

98 SAFETY OF GUSELKUMAB IN PATIENTS AGED ≥60 YEARS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES: A POOLED ANALYSIS OF REGISTRATIONAL TRIALS IN UC, CD, PSA AND PSO

Adam S. Faye, Shaji Sebastian, Victoria McCaffrey, Ivana Bravatà et autres

0 citationsGastroenterology

2026 conference-abstractOpenAlex

Mo1532 INTRAVENOUS AND SUBCUTANEOUS GUSELKUMAB INDUCTION ARE SIMILARLY EFFICACIOUS IN PATIENTS WITH ULCERATIVE COLITIS ACROSS WEIGHT QUARTILE AND BMI SUBGROUPS: WEEK 12 RESULTS FROM THE PHASE 3 QUASAR AND ASTRO STUDIES

Andres Yarur, Parakkal Deepak, Tadakazu Hisamatsu, Yelina Alvarez et autres

0 citationsGastroenterology

2026 conference-abstractOpenAlex

Mo1532 INTRAVENOUS AND SUBCUTANEOUS GUSELKUMAB INDUCTION ARE SIMILARLY EFFICACIOUS IN PATIENTS WITH ULCERATIVE COLITIS ACROSS WEIGHT QUARTILE AND BMI SUBGROUPS: WEEK 12 RESULTS FROM THE PHASE 3 QUASAR AND ASTRO STUDIES

Andres Yarur, Parakkal Deepak, Tadakazu Hisamatsu, Yelina Alvarez et autres

0 citationsGastrointestinal Endoscopy

2026 conference-abstractOpenAlex

Mo1516 MAYO ENDOSCOPIC SUBSCORE CHANGES IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH GUSELKUMAB IN THE QUASAR LONG-TERM EXTENSION

David T. Rubin, Jessica R. Allegretti, Yelina Alvarez, Thomas Baker et autres

0 citationsGastrointestinal Endoscopy

2026 conference-abstractOpenAlex

Mo1534 EFFICACY OF INTRAVENOUS AND SUBCUTANEOUS GUSELKUMAB INDUCTION BY WEIGHT AND BODY MASS INDEX IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM THE PHASE 3 GALAXI AND GRAVITI STUDIES

Parakkal Deepak, Andres Yarur, Tadakazu Hisamatsu, Rian Van Rampelbergh et autres

0 citationsGastroenterology

2026 articleOpenAlex

98 SAFETY OF GUSELKUMAB IN PATIENTS AGED ≥60 YEARS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES: A POOLED ANALYSIS OF REGISTRATIONAL TRIALS IN UC, CD, PSA AND PSO

Adam S. Faye, Shaji Sebastian, Victoria McCaffrey, Ivana Bravatà et autres

0 citationsGastrointestinal Endoscopy

2026 conference-abstractOpenAlex

Mo1516 MAYO ENDOSCOPIC SUBSCORE CHANGES IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH GUSELKUMAB IN THE QUASAR LONG-TERM EXTENSION

David T. Rubin, Jessica R. Allegretti, Yelina Alvarez, Thomas Baker et autres

0 citationsGastroenterology

2026 conference-abstractOpenAlex

Mo1534 EFFICACY OF INTRAVENOUS AND SUBCUTANEOUS GUSELKUMAB INDUCTION BY WEIGHT AND BODY MASS INDEX IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM THE PHASE 3 GALAXI AND GRAVITI STUDIES

Parakkal Deepak, Andres Yarur, Tadakazu Hisamatsu, Rian Van Rampelbergh et autres

0 citationsGastrointestinal Endoscopy

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.